GlassScriptPhysician profile
Alyssa C Miles
NPI 1851586986
$1,002.70
in general payments reported to CMS, 2019-2025
11 companies · $583 in 2025
The $583 reported for 2025 was more than what 83% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.43 · 2022: $91.63 · 2023: $85.89 · 2024: $213 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $881.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $356.05 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $200.32 | 2021-2025 | Lokelma, Farxiga |
| Amgen INC. | $117.42 | 2024-2025 | Krystexxa |
| Otsuka America Pharmaceutical, INC. | $77.64 | 2025 | Jynarque |
| Ardelyx, INC. | $51.19 | 2025 | Ibsrela |
| Vantive US Healthcare LLC | $50.39 | 2025 | Renal - Pd |
| Renalytix Ai, INC. | $44.08 | 2022-2023 | Kidneyintelx Blood Collection Convenience Kit |
| Nxstage Medical, INC. | $35.49 | 2022-2025 | Pureflow Sl, Nxstage System One |
| Veloxis Pharmaceuticals, INC. | $26.15 | 2022 | |
| Ani Pharmaceuticals, INC. | $23.56 | 2025 | Purified Cortrophin Gel |
| Calliditas Therapeutics US INC. | $20.41 | 2023 | Tarpeyo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.